/transcriptome sequencing

Ended Purchase Order Awarded Last action

Contract number
HHSN268201400203P
Awardee
Awarding agency
Obligated
$51,186

Award facts

Opportunity
  • NHLBICSBHG2014206DLM Solicitation number
Contract value 100% obligated
$51,186.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20892, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00001 · Final_close_process - -$98,780
Original award $149,966

About this award

The National Heart Lung and Blood Institute awarded a purchase order to Axeq Technologies, Inc. for $51,186.00 on August 8, 2014, for transcriptome sequencing services. Place of performance is Bethesda, Maryland. The order carried a firm fixed price and was ultimately closed on August 17, 2015. Axeq Technologies is a subsidiary of Macrogen, Inc., a genomic sequencing services provider.

Quick answers

Who was awarded contract HHSN268201400203P?

HHSN268201400203P was awarded to Axeq Technologies, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on August 8, 2014.

How much is contract HHSN268201400203P worth?

The government has obligated $51,186 on HHSN268201400203P.

Was contract HHSN268201400203P competed?

The extent of competition for HHSN268201400203P was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award